Key clinical point: Women who undergo anti-incontinence surgery show overall improvement in sexual function from baseline to 24 months postoperatively.
Major finding: The researchers observed no significant differences in mean Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire Short Form scores between the four treatment groups at the time of baseline (P = .07) or at the 12-and 24-month visits (P = .42 and P = .50, respectively).
Study details: A combined secondary analysis of 924 women enrolled in two trials.
Disclosures: This secondary analysis had no outside sources of funding. Dr. Glass Clark reported that she received a travel stipend from the Society of Gynecologic Surgeons, sponsored by OB-STATS. Her coauthors reported having no financial conflicts.
Glass Clark SM et al. Obstet Gynecol 2020;135(2):352-60.